Disease, Disability, and Injury Prevention and Control Special Emphasis Panel (SEP): Initial Review, 18766 [2011-8071]
Download as PDF
<![CDATA[
18766
Federal Register / Vol. 76, No. 65 / Tuesday, April 5, 2011 / Notices
conduct of research, demonstration
projects, and evaluations with respect to
health care; (2) in the fields of health
care quality research or health care
improvement; (3) in the practice of
medicine; (4) in other health
professions; (5) in representing the
private health care sector (including
health plans, providers, and purchasers)
or administrators of health care delivery
systems; (6) in the fields of health care
economics, information systems, law,
ethics, business, or public policy; and,
(7) in representing the interests of
patients and consumers of health care.
42 U.S.C. 299c(c)(2). Individuals are
particularly sought with experience and
success in activities specified in the
summary above.
DATES: Nominations should be received
on or before 60 days after date of
publication.
Nominations should be sent
to Ms. Karen Brooks, AHRQ, 540
Gaither Road, Room 3006, Rockville,
Maryland 20850. Nominations may also
be e-mailed to
Karen.Brooks@ahrq.hhs.gov.
ADDRESSES:
FOR FURTHER INFORMATION CONTACT:
Ms.
Karen Brooks, AHRQ, at (301) 427–
1801.
42 U.S.C.
299c provides that the Secretary shall
appoint to the National Advisory
Council for Healthcare Research and
Quality twenty one appropriately
qualified individuals. At least seventeen
members shall be representatives of the
public and at least one member shall be
a specialist in the rural aspects of one
or more of the professions or fields
listed in the above summary. In
addition, the Secretary designates, as ex
officio members, representatives from
other Federal agencies, principally
agencies that conduct or support health
care research, as well as Federal officials
the Secretary may consider appropriate.
42 U.S.C. 299c(c)(3). The Council meets
in the Washington, DC, metropolitan
area, generally in Rockville, Maryland,
approximately three times a year to
provide broad guidance to the Secretary
and AHRQ’s Director on the direction of
and programs undertaken by AHRQ.
Seven individuals will be selected
presently by the Secretary to serve on
the Council beginning with the meeting
in the spring of 2012. Members
generally serve 3-year terms.
Appointments are staggered to permit
an orderly rotation of membership.
Interested persons may nominate one
or more qualified persons for
membership on the Council. Selfnominations are accepted. Nominations
shall include: (1) A copy of the
srobinson on DSKHWCL6B1PROD with NOTICES
SUPPLEMENTARY INFORMATION:
VerDate Mar<15>2010
15:18 Apr 04, 2011
Jkt 223001
nominee’s resume or curriculum vitae;
and (2) a statement that the nominee is
willing to serve as a member of the
Council. Selected candidates will be
asked to provide detailed information
concerning their financial interests,
consultant positions and research grants
and contracts, to permit evaluation of
possible sources of conflict of interest.
Please note that Federally registered
lobbyists are not permitted to serve on
this advisory board. Please note that
once you are nominated, AHRQ may
consider your nomination for future
positions on the Council.
The Department seeks a broad
geographic representation. In addition,
AHRQ conducts and supports research
concerning priority populations, which
include: low-income groups; minority
groups; women; children; the elderly;
and individuals with special health care
needs, including individuals with
disabilities and individuals who need
chronic care or end-of-life health care.
See 42 U.S.C. 299(c). Nominations with
expertise in health care for these
priority populations are encouraged.
Dated: March 24, 2011.
Carolyn M. Clancy,
Director.
Contact Person for More Information:
Brenda Colley Gilbert, PhD, M.P.H., Director,
Extramural Research Program Office,
National Center for Chronic Disease
Prevention and Developmental Disabilities,
CDC, 1600 Clifton Road, NE., Mailstop K92,
Atlanta, Georgia 30333, Telephone: (770)
488–6295.
The Director, Management Analysis and
Services Office, has been delegated the
authority to sign Federal Register notices
pertaining to announcements of meetings and
other committee management activities, for
both the Centers for Disease Control and
Prevention and the Agency for Toxic
Substances and Disease Registry.
Dated: March 29, 2011.
Elaine L. Baker,
Director, Management Analysis and Services
Office, Centers for Disease Control and
Prevention.
[FR Doc. 2011–8071 Filed 4–4–11; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Medicare & Medicaid
Services
[CMS–9996–N]
Early Retiree Reinsurance Program
[FR Doc. 2011–8023 Filed 4–4–11; 8:45 am]
Centers for Medicare &
Medicaid Services (CMS), HHS.
ACTION: Notice.
BILLING CODE 4160–90–M
AGENCY:
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
SUMMARY:
Centers for Disease Control and
Prevention
Disease, Disability, and Injury
Prevention and Control Special
Emphasis Panel (SEP): Initial Review
The meeting announced below
concerns Epidemiologic Research and
Surveillance in Epilepsy, Funding
Opportunity Announcement (FOA)
DP11–003, initial review.
In accordance with Section 10(a)(2) of
the Federal Advisory Committee Act
(Pub. L. 92–463), the Centers for Disease
Control and Prevention (CDC)
announces the aforementioned meeting:
Time and Date: 11 a.m.–5 p.m., May 11,
2011 (Closed).
Place: Teleconference.
Status: The meeting will be closed to the
public in accordance with provisions set
forth in Section 552b(c)(4) and (6), Title 5
U.S.C., and the Determination of the Director,
Management Analysis and Services Office,
CDC, pursuant to Public Law 92–463.
Matters to be Discussed: The meeting will
include the initial review, discussion, and
evaluation of applications received in
response to ‘‘Epidemiologic Research and
Surveillance in Epilepsy FOA DP11–003,
initial review.’’
PO 00000
Frm 00054
Fmt 4703
Sfmt 4703
This notice announces that
CMS is exercising its authority under
section 1102(f) of the Affordable Care
Act to stop accepting applications for
the Early Retiree Reinsurance Program,
due to the availability of funds, as of
May 5, 2011.
DATES: Effective Date: This notice is
effective March 31, 2011.
FOR FURTHER INFORMATION CONTACT:
David Mlawsky, (410) 786–6851.
SUPPLEMENTARY INFORMATION:
I. Background
The Patient Protection and Affordable
Care Act (Pub. L. 111–148, enacted on
March 23, 2010) (the Affordable Care
Act), included a provision that
establishes the temporary Early Retiree
Reinsurance Program (ERRP), which
provides reimbursement to eligible
sponsors of employment-based plans for
a portion of the costs of providing
health coverage to early retirees (and
eligible spouses, surviving spouses, and
dependents of such retirees). Section
1102(a)(1) of the Affordable Care Act,
which is codified at 42 U.S.C.
18002(a)(1), requires the Secretary to
establish the program within 90 days of
enactment of the law (by June 21, 2010).
On May 5, 2010, we published an
E:\FR\FM\05APN1.SGM
05APN1
]]>Agencies
[Federal Register Volume 76, Number 65 (Tuesday, April 5, 2011)]
[Notices]
[Page 18766]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2011-8071]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
Disease, Disability, and Injury Prevention and Control Special
Emphasis Panel (SEP): Initial Review
The meeting announced below concerns Epidemiologic Research and
Surveillance in Epilepsy, Funding Opportunity Announcement (FOA) DP11-
003, initial review.
In accordance with Section 10(a)(2) of the Federal Advisory
Committee Act (Pub. L. 92-463), the Centers for Disease Control and
Prevention (CDC) announces the aforementioned meeting:
Time and Date: 11 a.m.-5 p.m., May 11, 2011 (Closed).
Place: Teleconference.
Status: The meeting will be closed to the public in accordance
with provisions set forth in Section 552b(c)(4) and (6), Title 5
U.S.C., and the Determination of the Director, Management Analysis
and Services Office, CDC, pursuant to Public Law 92-463.
Matters to be Discussed: The meeting will include the initial
review, discussion, and evaluation of applications received in
response to ``Epidemiologic Research and Surveillance in Epilepsy
FOA DP11-003, initial review.''
Contact Person for More Information: Brenda Colley Gilbert, PhD,
M.P.H., Director, Extramural Research Program Office, National
Center for Chronic Disease Prevention and Developmental
Disabilities, CDC, 1600 Clifton Road, NE., Mailstop K92, Atlanta,
Georgia 30333, Telephone: (770) 488-6295.
The Director, Management Analysis and Services Office, has been
delegated the authority to sign Federal Register notices pertaining
to announcements of meetings and other committee management
activities, for both the Centers for Disease Control and Prevention
and the Agency for Toxic Substances and Disease Registry.
Dated: March 29, 2011.
Elaine L. Baker,
Director, Management Analysis and Services Office, Centers for Disease
Control and Prevention.
[FR Doc. 2011-8071 Filed 4-4-11; 8:45 am]
BILLING CODE 4163-18-P
